Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy
Read the full article here
Read the full article here
Dense deposit disease doesn't usually make news. It is a rare and dangerous glomerulonephritis. Last we heard about it was when it lost its perch at MPGN type II nad was recast as one of a pair of C3 glomerulopathies, along side of C3 glomerulonephriotis.
But dense deposit disease is back in the news because the identitiy of those dense deposits has finally been discovered. It is apolipoprotein E. This was discovered by using laser capture microdissection along with confocal microscopy. Another nephrology mystery solved.
Read the full article here
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Rethinking…
Discovery of higher GSDMB expression in children with a genetic defect linked to asthma explains why they commonly experience viral infections and face an elevated…
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
Although scientific progress in HSCT is ongoing, gaps remain in both access to care and outcomes. An Education Session will review the latest research on…
In this issue of Blood, Chan et al report on in-depth studies of identical twins with idiopathic multicentric Castleman disease (iMCD), which provides a un
Researchers had people with Type 1 diabetes try a vegan diet for 12 weeks. Find out how it impacted their insulin needs here!
Geometric and topological properties of protein structures, including surface pockets, interior cavities, and cross channels, are of fundamental importance for proteins to carry out their…
The final in our 3-part quiz series based on the NLA’s 2024 update to their 2019 scientific statement on use of lipoprotein(a) in clinical practice…